- Filed
- Apr 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Apr 1, 2025 | 29.77M sh |
| Shares Diluted | Q3 2025 · Feb 28, 2025 | 29.73M sh |
| Shares Diluted | Q3 2025 · Feb 29, 2024 | 28.87M sh |
| Shares Diluted | Q3 2025 · Feb 29, 2024 | 29.67M sh |
| Cash And Equivalents | Q3 2025 · Feb 28, 2025 | $29.41M |
| Cash And Equivalents | Q3 2025 · May 31, 2024 | $49.16M |
| Current Liabilities | Q3 2025 · Feb 28, 2025 | $16.06M |
| Current Liabilities | Q3 2025 · May 31, 2024 | $10.51M |
| Total Liabilities | Q3 2025 · Feb 28, 2025 | $21.4M |
| Total Liabilities | Q3 2025 · May 31, 2024 | $16.32M |
| Current Assets | Q3 2025 · Feb 28, 2025 | $91.7M |
| Current Assets | Q3 2025 · May 31, 2024 | $97.85M |
| Total Assets | Q3 2025 · Feb 28, 2025 | $145.61M |
| Total Assets | Q3 2025 · May 31, 2024 | $127.91M |
| Eps Diluted | Q3 2025 · Feb 28, 2025 | −$0.02 |
| Eps Diluted | Q3 2025 · Feb 29, 2024 | −$0.05 |
| Eps Diluted | Q3 2025 · Feb 29, 2024 | $0.31 |
| Eps Basic | Q3 2025 · Feb 28, 2025 | −$0.02 |
| Eps Basic | Q3 2025 · Feb 29, 2024 | −$0.05 |
| Eps Basic restated | Q3 2025 · Feb 29, 2024 | −$0.32 |
| Sga Expense | Q3 2025 · Feb 28, 2025 | $5.16M |
| Sga Expense | Q3 2025 · Feb 29, 2024 | $3.06M |
| Sga Expense | Q3 2025 · Feb 29, 2024 | $9.99M |
| Rd Expense | Q3 2025 · Feb 28, 2025 | $3.14M |
| Rd Expense | Q3 2025 · Feb 29, 2024 | $2.14M |
| Rd Expense | Q3 2025 · Feb 29, 2024 | $6.57M |
| Net Income | Q3 2025 · Feb 28, 2025 | −$643K |
| Net Income | Q3 2025 · Feb 29, 2024 | −$1.47M |
| Net Income | Q3 2025 · Feb 29, 2024 | $9.29M |
| Net Income | Q3 2025 · Feb 28, 2024 | −$1.47M |
| Operating Income | Q3 2025 · Feb 28, 2025 | −$1.12M |
| Operating Income | Q3 2025 · Feb 29, 2024 | −$2.05M |
| Operating Income | Q3 2025 · Feb 29, 2024 | $7.54M |
| Gross Profit | Q3 2025 · Feb 28, 2025 | $7.18M |
| Gross Profit | Q3 2025 · Feb 29, 2024 | $3.16M |
| Gross Profit | Q3 2025 · Feb 29, 2024 | $24.1M |
| Cost Of Revenue | Q3 2025 · Feb 28, 2025 | $11.12M |
| Cost Of Revenue | Q3 2025 · Feb 29, 2024 | $4.41M |
| Cost Of Revenue | Q3 2025 · Feb 29, 2024 | $25.52M |
| Revenue | Q3 2025 · Feb 28, 2025 | $18.31M |
| Revenue | Q3 2025 · Feb 29, 2024 | $7.56M |
| Revenue | Q3 2025 · Feb 29, 2024 | $49.62M |
| Capex | Q3 2025 · Feb 29, 2024 | $703K |
| Operating Cash Flow | Q3 2025 · Feb 29, 2024 | $532K |
| Stockholders Equity | Q3 2025 · Feb 29, 2024 | $86.5M |
| Stockholders Equity | Q3 2025 · Feb 28, 2024 | $86.5M |
| Stockholders Equity | Q3 2025 · Nov 30, 2023 | $87.15M |
| Stockholders Equity | Q3 2025 · May 31, 2023 | $75.6M |